Hematologic toxicity assessment in solid tumor patients treated with cetuximab: A pooled analysis of 18 randomized controlled trials

Int J Cancer. 2016 Jun 1;138(11):2771-3. doi: 10.1002/ijc.30004. Epub 2016 Feb 21.

Authors

Ran Cui¹, Li Chu¹, Zhu-Qing Liu¹, Yuan-Yuan Xiao¹, Xiao-Li Zhu², Yi-Jing Chen¹, Qing Xu¹

Affiliations

¹ Department of Oncology, Shanghai Tenth People's Hospital, Tongji University, School of Medicine, Zhabei District, Shanghai, 200072, China.
² State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University, Shanghai, 200433, China.

PMID: 26789526
DOI: 10.1002/ijc.30004

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects*
Antineoplastic Agents / adverse effects*
Humans
Neoplasms / drug therapy*
Neutropenia / chemically induced*

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents